Report ID: ARS3543 | Category: Healthcare and Pharmaceuticals | Pages: 128 | Format: PDF | Published Date: September 07,2023
Table of Content 1 CAR T-Cell Therapy Market Introduction and Overview 1.1 CAR T-Cell Therapy Definition 1.2 Research Purposes 1.3 Report Timeline 1.4 Economic Analysis of Global Regions 1.5 Inflation Analysis 1.6 The Impact of the Russian-Ukrainian War on the Market 1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global 2 Global CAR T-Cell Therapy Historical Market Analysis by Type 2.1 Market Size Analysis by Types 2.2 Global CAR T-Cell Therapy Revenue and Market Share by Type 3 Global CAR T-Cell Therapy Historical Market Analysis by Application 3.1 Market Size Analysis by Application 3.2 Global CAR T-Cell Therapy Revenue Market Share by Application (2018-2023) 4 Global Market Growth Trends Analysis 4.1 Global CAR T-Cell Therapy Market Size (2018-2023) 4.2 CAR T-Cell Therapy Growth Trends Analysis by Regions 4.2.1 CAR T-Cell Therapy Market Size by Regions: 2018 VS 2023 VS 2029 4.2.2 CAR T-Cell Therapy Historic Revenue Market Size by Regions (2018-2023) 4.2.3 North America CAR T-Cell Therapy Market Size (2018-2023) 4.2.4 Europe CAR T-Cell Therapy Market Size (2018-2023) 4.2.5 Asia-Pacific CAR T-Cell Therapy Market Size (2018-2023) 4.2.6 Latin America CAR T-Cell Therapy Market Size (2018-2023) 4.2.7 Middle East & Africa CAR T-Cell Therapy Market Size (2018-2023) 5 North America 5.1 North America CAR T-Cell Therapy Revenue by Countries 5.1.1 North America CAR T-Cell Therapy Revenue by Countries (2018-2023) 5.2 North America CAR T-Cell Therapy Revenue by Types 5.3 North America CAR T-Cell Therapy Revenue by Applications 5.4 United States 5.5 Canada 6 Asia Pacific 6.1 Asia Pacific CAR T-Cell Therapy Revenue by Countries 6.1.1 Asia Pacific CAR T-Cell Therapy Revenue by Countries (2018-2023) 6.2 Asia Pacific CAR T-Cell Therapy Revenue by Types 6.3 Asia Pacific CAR T-Cell Therapy Revenue by Applications 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe CAR T-Cell Therapy Revenue by Countries 7.1.1 Europe CAR T-Cell Therapy Revenue by Countries (2018-2023) 7.2 Europe CAR T-Cell Therapy Revenue by Types 7.3 Europe CAR T-Cell Therapy Revenue by Applications 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 7.9 Spain 7.10 Nordic 8 Latin America 8.1 Latin America CAR T-Cell Therapy Revenue by Countries 8.1.1 Latin America CAR T-Cell Therapy Revenue by Countries (2018-2023) 8.2 Latin America CAR T-Cell Therapy Revenue by Types 8.3 Latin America CAR T-Cell Therapy Revenue by Applications 8.4 Brazil 8.5 Argentina 8.6 Mexico 9 Middle East & Africa 9.1 Middle East & Africa CAR T-Cell Therapy Revenue by Countries 9.1.1 Middle East & Africa CAR T-Cell Therapy Revenue by Countries (2018-2023) 9.2 Middle East & Africa CAR T-Cell Therapy Revenue by Types 9.3 Middle East & Africa CAR T-Cell Therapy Revenue by Applications 9.4 Egypt 9.5 South Africa 9.6 UAE 9.7 Turkey 9.8 Saudi Arabia 10 Global CAR T-Cell Therapy Market Competition, by Players 10.1 Global CAR T-Cell Therapy Revenue and Market Share by Players 10.2 Market Concentration Rate 10.2.1 Top 3 CAR T-Cell Therapy Players Market Share in 2022 10.2.2 Top 6 CAR T-Cell Therapy Players Market Share in 2022 10.2.3 Market Competition Trend 10.3 CAR T-Cell Therapy Players Head Office, Business Provided 10.4 CAR T-Cell Therapy Mergers & Acquisitions 10.5 CAR T-Cell Therapy New Entrants and Expansion Plans 11 Players Profiles11.1 Autolus Therapeutics 11.1.1 Autolus Therapeutics Company Profile 11.1.2 CAR T-Cell Therapy Product Overview 11.1.3 Autolus Therapeutics CAR T-Cell Therapy Market Performance (2018-2023) 11.1.4 Autolus Therapeutics Business Overview 11.1.5 Recent Developments and Plans 11.2 CARsgen Therapeutics Co.Ltd. 11.2.1 CARsgen Therapeutics Co.Ltd. Company Profile 11.2.2 CAR T-Cell Therapy Product Overview 11.2.3 CARsgen Therapeutics Co.Ltd. CAR T-Cell Therapy Market Performance (2018-2023) 11.2.4 CARsgen Therapeutics Co.Ltd. Business Overview 11.2.5 Recent Developments and Plans 11.3 Juno Therapeutics, Inc. 11.3.1 Juno Therapeutics, Inc. Company Profile 11.3.2 CAR T-Cell Therapy Product Overview 11.3.3 Juno Therapeutics, Inc. CAR T-Cell Therapy Market Performance (2018-2023) 11.3.4 Juno Therapeutics, Inc. Business Overview 11.3.5 Recent Developments and Plans 11.4 Sorrento Therapeutics, Inc. 11.4.1 Sorrento Therapeutics, Inc. Company Profile 11.4.2 CAR T-Cell Therapy Product Overview 11.4.3 Sorrento Therapeutics, Inc. CAR T-Cell Therapy Market Performance (2018-2023) 11.4.4 Sorrento Therapeutics, Inc. Business Overview 11.4.5 Recent Developments and Plans 11.5 Bluebird bio, Inc. 11.5.1 Bluebird bio, Inc. Company Profile 11.5.2 CAR T-Cell Therapy Product Overview 11.5.3 Bluebird bio, Inc. CAR T-Cell Therapy Market Performance (2018-2023) 11.5.4 Bluebird bio, Inc. Business Overview 11.5.5 Recent Developments and Plans 11.6 CELGENE CORPORATION 11.6.1 CELGENE CORPORATION Company Profile 11.6.2 CAR T-Cell Therapy Product Overview 11.6.3 CELGENE CORPORATION CAR T-Cell Therapy Market Performance (2018-2023) 11.6.4 CELGENE CORPORATION Business Overview 11.6.5 Recent Developments and Plans 11.7 Eureka Therapeutics Inc. 11.7.1 Eureka Therapeutics Inc. Company Profile 11.7.2 CAR T-Cell Therapy Product Overview 11.7.3 Eureka Therapeutics Inc. CAR T-Cell Therapy Market Performance (2018-2023) 11.7.4 Eureka Therapeutics Inc. Business Overview 11.7.5 Recent Developments and Plans 11.8 Avacta Life Sciences Ltd. 11.8.1 Avacta Life Sciences Ltd. Company Profile 11.8.2 CAR T-Cell Therapy Product Overview 11.8.3 Avacta Life Sciences Ltd. CAR T-Cell Therapy Market Performance (2018-2023) 11.8.4 Avacta Life Sciences Ltd. Business Overview 11.8.5 Recent Developments and Plans 11.9 Calyxt Inc. 11.9.1 Calyxt Inc. Company Profile 11.9.2 CAR T-Cell Therapy Product Overview 11.9.3 Calyxt Inc. CAR T-Cell Therapy Market Performance (2018-2023) 11.9.4 Calyxt Inc. Business Overview 11.9.5 Recent Developments and Plans 11.10 Celyad Oncology SA 11.10.1 Celyad Oncology SA Company Profile 11.10.2 CAR T-Cell Therapy Product Overview 11.10.3 Celyad Oncology SA CAR T-Cell Therapy Market Performance (2018-2023) 11.10.4 Celyad Oncology SA Business Overview 11.10.5 Recent Developments and Plans 11.11 Fortress Biotech, Inc 11.11.1 Fortress Biotech, Inc Company Profile 11.11.2 CAR T-Cell Therapy Product Overview 11.11.3 Fortress Biotech, Inc CAR T-Cell Therapy Market Performance (2018-2023) 11.11.4 Fortress Biotech, Inc Business Overview 11.11.5 Recent Developments and Plans 11.12 IMMUNE THERAPEUTICS, INC 11.12.1 IMMUNE THERAPEUTICS, INC Company Profile 11.12.2 CAR T-Cell Therapy Product Overview 11.12.3 IMMUNE THERAPEUTICS, INC CAR T-Cell Therapy Market Performance (2018-2023) 11.12.4 IMMUNE THERAPEUTICS, INC Business Overview 11.12.5 Recent Developments and Plans 11.13 Gilead Sciences, Inc. 11.13.1 Gilead Sciences, Inc. Company Profile 11.13.2 CAR T-Cell Therapy Product Overview 11.13.3 Gilead Sciences, Inc. CAR T-Cell Therapy Market Performance (2018-2023) 11.13.4 Gilead Sciences, Inc. Business Overview 11.13.5 Recent Developments and Plans 11.14 Novartis AG 11.14.1 Novartis AG Company Profile 11.14.2 CAR T-Cell Therapy Product Overview 11.14.3 Novartis AG CAR T-Cell Therapy Market Performance (2018-2023) 11.14.4 Novartis AG Business Overview 11.14.5 Recent Developments and Plans 11.15 Alaunos Therapeutics, Inc. 11.15.1 Alaunos Therapeutics, Inc. Company Profile 11.15.2 CAR T-Cell Therapy Product Overview 11.15.3 Alaunos Therapeutics, Inc. CAR T-Cell Therapy Market Performance (2018-2023) 11.15.4 Alaunos Therapeutics, Inc. Business Overview 11.15.5 Recent Developments and Plans 12 Global CAR T-Cell Therapy Forecast Market Analysis by Type 12.1 Global CAR T-Cell Therapy Revenue Market Forecast by Type (2023-2029) 13 Global CAR T-Cell Therapy Forecast Market Analysis by Application 13.1 CAR T-Cell Therapy Revenue Market Forecast by Application (2023-2029) 14 Global Market Growth Forecast Analysis 14.1 Global CAR T-Cell Therapy Forecast Market Size (2023-2029) 14.2 CAR T-Cell Therapy Growth Trends Forecast Analysis by Regions 14.2.1 CAR T-Cell Therapy Revenue Forecast Market Size by Regions (2023-2029) 14.2.2 North America CAR T-Cell Therapy Forecast Market Size (2023-2029) 14.2.3 Europe CAR T-Cell Therapy Forecast Market Size (2023-2029) 14.2.4 Asia-Pacific CAR T-Cell Therapy Forecast Market Size (2023-2029) 14.2.5 Latin America CAR T-Cell Therapy Forecast Market Size (2023-2029) 14.2.6 Middle East & Africa CAR T-Cell Therapy Forecast Market Size (2023-2029) 15 CAR T-Cell Therapy Industry Dynamic Analysis 15.1 CAR T-Cell Therapy Market Trends Analysis 15.2 CAR T-Cell Therapy Market Drivers Analysis 15.3 CAR T-Cell Therapy Market Challenges Analysis 15.4 CAR T-Cell Therapy Market Restraints Analysis
It contains all the geographic trends, and market analysis for global market